Tumor Organoids for Functional Precision Oncology
Researchers are using patient-derived tumor organoids to match patients with optimal treatments
Miriam Bergeret, MSc
Miriam Bergeret is a freelance writer based in Toronto. She obtained her MSc in laboratory medicine and pathobiology from the University of Toronto and is a strong advocate of rare disease research.
Articles by Miriam Bergeret, MSc
How NGS is Making Personalized Cancer Vaccines a Reality
Next-generation sequencing has revolutionized the detection of tumor neoantigens
A New Generation of Malaria Vaccines
Promising results from the first in-human trials of genetically engineered malaria vaccines
A Step Toward Standardized Residual Disease Testing in Acute Myeloid Leukemia
Minimal residual disease is a powerful prognostic factor, but expert says it’s not yet an exact science
Flow Cytometry Reveals Immune System Dysregulation in Coronavirus Patients
How multiparameter flow cytometry can give a rapid picture of a patient’s immune response from a single blood sample